Pacira Biosciences Inc (PCRX)
$36.39 0.00% Close Oct 30, 2026 Live
Pacira Biosciences stock today
Pacira Biosciences closed at $36.39 on October 30, 2026, unchanged on the day. Over the past year it returned +71.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.43 billion.
$20.00$30.00
NovJan 2026MarMayJulSep
| Period | PCRX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +45.3% | -0.9% |
| 3 months | +34.9% | +2.1% |
| Year to date | +40.6% | +11.7% |
| 1 year | +71.1% | +12.4% |
| 3 years | +31.0% | +88.5% |
| 5 years | -30.4% | +76.0% |
Key statistics
- Market value
- $1.43B
- P/E (trailing)
- 101.1
- Forward P/E
- 11.5
- Price / sales
- 1.9
- 52-week range
- $19.16 to $36.42
- Next report
- Nov 5, 2026 (estimated)
About Pacira Biosciences
Pacira BioSciences develops and sells injectable pain management pharmaceuticals.
Sector: Health Care
More on Pacira Biosciences
- Financials: revenue, earnings and segmentsRevenue +4% in the year to Dec 2025
- Valuation: P/E history and peersP/E 101.1, median 65.4 at its last 5 year ends
- Returns: what $1,000 became$1,000 ten years ago is $1,098 today
No forecast, no recommendation. This page describes Pacira Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.